One in Five US Orphan Drug Designations This Month Goes to Korean Firms
Three of 14 therapeutics designated as US FDA orphan drugs this month were developed by Korean firms Yuhan, ABL Bio, and Xcellomol, boosting technology export prospects.
Briefing on user experience design trends, UX research developments, and product design best practices. For product and design teams.
Curated AI briefing - Updates with new content
Create your own AI-powered briefing on any topic — delivered automatically.
You might also enjoy these briefings
Track product launches, feature releases, and product strategy news across...
Follow student engagement strategies, learning science news, and education...
Track Apple, Google, and Microsoft stock news in one daily briefing. Covers...
Weekly digest of the latest digital marketing strategies, campaign trends,...
Enjoyed this briefing? Get it delivered to your inbox!
Create Free Account